Revision as of 13:08, 24 February 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,071 edits Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: ChEMBL.← Previous edit |
Latest revision as of 20:33, 10 March 2024 edit undoInternetArchiveBot (talk | contribs)Bots, Pending changes reviewers5,388,266 edits Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.5) (Maxim Masiutin - 17955 |
(39 intermediate revisions by 29 users not shown) |
Line 1: |
Line 1: |
|
|
{{Short description|Chemical compound}} |
|
{{Drugbox |
|
{{Drugbox |
|
| verifiedrevid = 400290854 |
|
| verifiedrevid = 415683864 |
|
| IUPAC_name = 2-(7-methoxy-1,3-benzodioxol-5-yl)ethanamine |
|
| IUPAC_name = 2-(7-Methoxy-1,3-benzodioxol-5-yl)ethanamine |
|
| image = Lophophine.png |
|
| image = Lophophine.png |
|
|
|
|
| InChI = 1/C10H13NO3/c1-12-8-4-7(2-3-11)5-9-10(8)14-6-13-9/h4-5H,2-3,6,11H2,1H3 |
|
|
|
<!--Clinical data--> |
|
| InChIKey = ORXQUAPZHKCCAX-UHFFFAOYAH |
|
|
|
| tradename = |
|
⚫ |
| pregnancy_category = |
|
⚫ |
| legal_status = Uncontrolled <small>(but may be covered under the ] in the ] and under similar bills in other countries due to its similarity to ] and ])</small> |
|
⚫ |
| routes_of_administration = ] |
|
|
|
|
|
<!--Pharmacokinetic data--> |
|
⚫ |
| bioavailability = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
|
|
|
|
<!--Identifiers--> |
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
⚫ |
| CAS_number = 23693-38-1 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = C68IB79RC2 |
|
⚫ |
| ATC_prefix = none |
|
⚫ |
| ATC_suffix = |
|
⚫ |
| PubChem = 90239 |
|
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
⚫ |
| ChemSpiderID = 81465 |
|
|
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
|
| ChEMBL = 159620 |
|
| ChEMBL = 159620 |
|
|
|
|
|
<!--Chemical data--> |
|
⚫ |
| C=10 | H=13 | N=1 | O=3 |
|
⚫ |
| smiles = O1c2cc(cc(OC)c2OC1)CCN |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C10H13NO3/c1-12-8-4-7(2-3-11)5-9-10(8)14-6-13-9/h4-5H,2-3,6,11H2,1H3 |
|
| StdInChI = 1S/C10H13NO3/c1-12-8-4-7(2-3-11)5-9-10(8)14-6-13-9/h4-5H,2-3,6,11H2,1H3 |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = ORXQUAPZHKCCAX-UHFFFAOYSA-N |
|
| StdInChIKey = ORXQUAPZHKCCAX-UHFFFAOYSA-N |
⚫ |
| CAS_number = 23693-38-1 |
|
⚫ |
| ATC_prefix = none |
|
⚫ |
| ATC_suffix = |
|
⚫ |
| PubChem = 90239 |
|
⚫ |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
⚫ |
| ChemSpiderID = 81465 |
|
⚫ |
| C = 10 | H = 13 | N = 1 | O = 3 |
|
|
| molecular_weight = 195.22 g/mol |
|
⚫ |
| smiles = O1c2cc(cc(OC)c2OC1)CCN |
|
⚫ |
| bioavailability = |
|
⚫ |
| metabolism = |
|
⚫ |
| elimination_half-life = |
|
⚫ |
| excretion = |
|
⚫ |
| pregnancy_category = ? |
|
⚫ |
| legal_status = Uncontrolled <small>(but may be covered under the ] in the ] and under similar bills in other countries due to its similarity to ] and ])</small> |
|
⚫ |
| routes_of_administration = ] |
|
|
}} |
|
}} |
|
|
|
|
|
'''Lophophine''', also known as '''3-methoxy-4,5-methylenedioxyphenethylamine''' ('''MMDPEA'''; '''5-Methoxy-MDPEA'''), is a ] and ] ] of the ] class. It is the ]-] ] of ], and is also closely related to ]. |
|
'''Lophophine''' ('''MMDPEA''' or '''3-methoxy-4,5-methylenedioxyphenethylamine''') is a putative ] and ] ] of the ] class. It is the ]-] ] of ], and is also closely related to ]. |
|
|
|
|
|
] previously suggested that lophophine may be a ] of ] due to it being the only logical ] for the ] of several ]s known to be present in the ]. Subsequently, it was indeed shown to be a minor component of both Peyote and ].<ref name="pmid18720674">{{cite journal | author = Bruhn JG, El-Seedi HR, Stephanson N, Beck O, Shulgin AT | title = Ecstasy analogues found in cacti | journal = ] | volume = 40 | issue = 2 | pages = 219–22 | year = 2008 | month = June | pmid = 18720674 | doi = | url = }}</ref> |
|
] originally suggested that lophophine may be a ] of ] (''Lophophora williamsii'') due to it being the only logical ] for the ] of several ]s known to be present in this cactus species.<ref name = Shul>{{Cite book | author = A. Shulgin and A. Shulgin | date = 1991 | title = Pihkal | pages = 701–702 | publisher = Transform Press | location = Berkeley}}</ref> Subsequently, lophophine was indeed shown to be a minor component of both peyote and ].<ref name="pmid18720674">{{cite journal |vauthors=Bruhn JG, El-Seedi HR, Stephanson N, Beck O, Shulgin AT | title = Ecstasy analogues found in cacti | journal = ] | volume = 40 | issue = 2 | pages = 219–22 |date=June 2008 | pmid = 18720674 | doi = 10.1080/02791072.2008.10400635| citeseerx = 10.1.1.689.4014 | s2cid = 11251286 }}</ref> |
|
|
|
|
|
Shulgin reports that lophophine is ] in the ] range of 150-250 mg. He states that at these doses, MMDPEA is very similar to mescaline in action, and that a peaceful elevation of ], ], enhancement of ] ], and the generation of ] ] are all present. At dosages above 300 mg, ]s that resemble those of standard doses of mescaline are said to begin to appear. Shulgin also notes that in contrast to mescaline, lophophine causes little ] or ]. |
|
Shulgin reports that lophophine is active in the ] range of 150–250 mg. He states that at these doses, lophophine has some similarity to mescaline in action, in producing a peaceful elevation of ], ], and mild enhancement of ] ], but without the generation of ] ]. Shulgin also notes that (in contrast to mescaline), lophophine causes no ].<ref name = Shul/> |
|
|
|
|
|
== See also == |
|
== See also == |
|
* ] |
|
|
* ] |
|
|
* ] |
|
* ] |
|
|
|
|
Line 44: |
Line 53: |
|
== External links == |
|
== External links == |
|
* |
|
* |
|
⚫ |
* {{Webarchive|url=https://web.archive.org/web/20140216210730/http://leda.lycaeum.org/?ID=16291 |date=2014-02-16 }} |
|
* |
|
⚫ |
* |
|
|
|
|
|
|
|
|
|
⚫ |
{{Hallucinogens}} |
|
{{Entactogens}} |
|
{{Entactogens}} |
|
|
{{Monoamine releasing agents}} |
⚫ |
{{Hallucinogens}} |
|
|
|
{{Serotonin receptor modulators}} |
|
{{Serotonergics}} |
|
|
{{Phenethylamines}} |
|
{{Phenethylamines}} |
|
|
|
|
Line 58: |
Line 66: |
|
] |
|
] |
|
] |
|
] |
|
|
] |